Prenatal transmission of subtype C HIV-1 in Zimbabwe: HIV-1 RNA and DNA in maternal and cord blood.
暂无分享,去创建一个
D. Katzenstein | P. Mason | C. Contag | H. Guevara | L. Zijenah | K. Mahomed | O. Tobaiwa | E. Johnston | M. Hendry | Elizabeth Johnston
[1] R. Biggar,et al. Virus levels in untreated African infants infected with human immunodeficiency virus type 1. , 1999, The Journal of infectious diseases.
[2] S. Blum,et al. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women. , 1999, Obstetrics and gynecology.
[3] D. Harris,et al. RISK FACTORS FOR PERINATAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 IN WOMEN TREATED WITH ZIDOVUDINE , 1999 .
[4] L. Kalish,et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. , 1999, The New England journal of medicine.
[5] A. Adimora,et al. Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina. , 1999, The Journal of infectious diseases.
[6] D. Katzenstein,et al. Serum level of maternal human immunodeficiency virus (HIV) RNA, infant mortality, and vertical transmission of HIV in Zimbabwe. , 1999, The Journal of infectious diseases.
[7] A. Lazzarin,et al. Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection. , 1999, AIDS.
[8] M. Kalish,et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. , 1999, The Journal of infectious diseases.
[9] M. Kalish,et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. , 1999, AIDS.
[10] Christopher D. Pilcher,et al. Comparison of NucliSens and Roche Monitor Assays for Quantitation of Levels of Human Immunodeficiency Virus Type 1 RNA in Plasma , 1999, Journal of Clinical Microbiology.
[11] R. Pilon,et al. Amplicor HIV monitor, NASBA HIV-1 RNA QT and quantiplex HIV RNA version 2.0 viral load assays: a Canadian evaluation. , 1998, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[12] B. Clotet,et al. Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[13] M. Kalish,et al. Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. Perinatal AIDS Collaborative Transmission Study. , 1998, AIDS.
[14] B L Herring,et al. Genetic evaluation of suspected cases of transient HIV-1 infection of infants. , 1998, Science.
[15] M. Gill,et al. Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper , 1997, Journal of clinical microbiology.
[16] J. Mullins,et al. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS , 1997, Journal of virology.
[17] L. Heyndrickx,et al. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. , 1997, Journal of virological methods.
[18] C. Rouzioux,et al. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[19] R. Biggar,et al. Blood collection on filter paper: a practical approach to sample collection for studies of perinatal HIV transmission. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[20] M. Kalish,et al. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study. , 1997, The Journal of infectious diseases.
[21] G. Learn,et al. Mother-to-infant transmission of human immunodeficiency virus type 1 involving five envelope sequence subtypes , 1997, Journal of virology.
[22] F. Brun-Vézinet,et al. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma , 1996, Journal of clinical microbiology.
[23] T. Quinn,et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. , 1996, The Journal of infectious diseases.
[24] E. De Clercq,et al. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[25] A. Rodrigo,et al. Genetic subtyping of human immunodeficiency virus using a heteroduplex mobility assay. , 1995, PCR methods and applications.
[26] I. Chen,et al. Clearance of HIV infection in a perinatally infected infant , 1995, The New England journal of medicine.
[27] E. Karita,et al. An assessment of the timing of mother-to-child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. , 1994, Journal of acquired immune deficiency syndromes.
[28] J. Levy,et al. Features of HIV-1 that could influence maternal-child transmission. , 1994, JAMA.
[29] T. Kievits,et al. Qualitative and quantitative detection of HIV‐1 RNA by nucleic acid sequence‐based amplification , 1993, AIDS.
[30] D. van Strijp,et al. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. , 1993, Journal of virological methods.
[31] B. Williams,et al. Quantitative assessment of HIV-1 DNA load by coamplification of HIV-1 gag and HLA-DQ-α genes , 1991 .
[32] D. Katzenstein,et al. Inhibition of human immunodeficiency virus gene amplification by heparin , 1991, Journal of clinical microbiology.
[33] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.
[34] M. Newell,et al. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. The European Collaborative Study. , 1999, AIDS.
[35] C. Boucher,et al. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[36] C. Katlama,et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. , 1997, The Journal of infectious diseases.
[37] C. Giaquinto,et al. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. The Working Group on Mother-To-Child Transmission of HIV. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[38] C. Hankins,et al. Diagnosis of vertical HIV-1 transmission using the polymerase chain reaction and dried blood spot specimens. , 1992, Journal of acquired immune deficiency syndromes.